TeleECHO Series: Immuno-oncology/Tyrosine Kinase Inhibitor Combination Therapies for the Treatment of Advanced Renal Cell Carcinoma: Which of Your Patients May Benefit from Their Use in the Firstline Setting?

Pre-test